197 related articles for article (PubMed ID: 22334690)
1. Histone deacetylase 6 (HDAC6) deacetylates survivin for its nuclear export in breast cancer.
Riolo MT; Cooper ZA; Holloway MP; Cheng Y; Bianchi C; Yakirevich E; Ma L; Chin YE; Altura RA
J Biol Chem; 2012 Mar; 287(14):10885-93. PubMed ID: 22334690
[TBL] [Abstract][Full Text] [Related]
2. Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activity.
Wang H; Holloway MP; Ma L; Cooper ZA; Riolo M; Samkari A; Elenitoba-Johnson KS; Chin YE; Altura RA
J Biol Chem; 2010 Nov; 285(46):36129-37. PubMed ID: 20826784
[TBL] [Abstract][Full Text] [Related]
3. Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation.
Liu Y; Peng L; Seto E; Huang S; Qiu Y
J Biol Chem; 2012 Aug; 287(34):29168-74. PubMed ID: 22778253
[TBL] [Abstract][Full Text] [Related]
4. HDAC6 deacetylates Ku70 and regulates Ku70-Bax binding in neuroblastoma.
Subramanian C; Jarzembowski JA; Opipari AW; Castle VP; Kwok RP
Neoplasia; 2011 Aug; 13(8):726-34. PubMed ID: 21847364
[TBL] [Abstract][Full Text] [Related]
5. Novel Interaction of Class IIb Histone Deacetylase 6 (HDAC6) with Class IIa HDAC9 Controls Gonadotropin Releasing Hormone (GnRH) Neuronal Cell Survival and Movement.
Salian-Mehta S; Xu M; McKinsey TA; Tobet S; Wierman ME
J Biol Chem; 2015 May; 290(22):14045-56. PubMed ID: 25873389
[TBL] [Abstract][Full Text] [Related]
6. XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer.
Cheng Y; Holloway MP; Nguyen K; McCauley D; Landesman Y; Kauffman MG; Shacham S; Altura RA
Mol Cancer Ther; 2014 Mar; 13(3):675-86. PubMed ID: 24431073
[TBL] [Abstract][Full Text] [Related]
7. Nucleocytoplasmic shuttling and the biological activity of mouse survivin are regulated by an active nuclear export signal.
Stauber RH; Rabenhorst U; Rekik A; Engels K; Bier C; Knauer SK
Traffic; 2006 Nov; 7(11):1461-72. PubMed ID: 16984408
[TBL] [Abstract][Full Text] [Related]
8. HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.
Medler TR; Craig JM; Fiorillo AA; Feeney YB; Harrell JC; Clevenger CV
Mol Cancer Res; 2016 Oct; 14(10):994-1008. PubMed ID: 27358110
[TBL] [Abstract][Full Text] [Related]
9. Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention.
Bertos NR; Gilquin B; Chan GK; Yen TJ; Khochbin S; Yang XJ
J Biol Chem; 2004 Nov; 279(46):48246-54. PubMed ID: 15347674
[TBL] [Abstract][Full Text] [Related]
10. Function of histone deacetylase 6 as a cofactor of nuclear receptor coregulator LCoR.
Palijan A; Fernandes I; Bastien Y; Tang L; Verway M; Kourelis M; Tavera-Mendoza LE; Li Z; Bourdeau V; Mader S; Yang XJ; White JH
J Biol Chem; 2009 Oct; 284(44):30264-74. PubMed ID: 19744931
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction of CREB binding protein (CBP) with nuclear transport proteins and modulation by HDAC inhibitors.
Ryan CM; Harries JC; Kindle KB; Collins HM; Heery DM
Cell Cycle; 2006 Sep; 5(18):2146-52. PubMed ID: 16969114
[TBL] [Abstract][Full Text] [Related]
12. SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin.
Jin JS; Tsao TY; Sun PC; Yu CP; Tzao C
Pathol Oncol Res; 2012 Jul; 18(3):713-20. PubMed ID: 22270866
[TBL] [Abstract][Full Text] [Related]
13. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin.
RodrÃguez JA; Span SW; Ferreira CG; Kruyt FA; Giaccone G
Exp Cell Res; 2002 Apr; 275(1):44-53. PubMed ID: 11925104
[TBL] [Abstract][Full Text] [Related]
14. Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cells.
Rao R; Nalluri S; Kolhe R; Yang Y; Fiskus W; Chen J; Ha K; Buckley KM; Balusu R; Coothankandaswamy V; Joshi A; Atadja P; Bhalla KN
Mol Cancer Ther; 2010 Apr; 9(4):942-52. PubMed ID: 20371724
[TBL] [Abstract][Full Text] [Related]
15. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.
Saji S; Kawakami M; Hayashi S; Yoshida N; Hirose M; Horiguchi S; Itoh A; Funata N; Schreiber SL; Yoshida M; Toi M
Oncogene; 2005 Jun; 24(28):4531-9. PubMed ID: 15806142
[TBL] [Abstract][Full Text] [Related]
16. Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis.
Chan KS; Wong CH; Huang YF; Li HY
Cell Death Dis; 2010 Jul; 1(7):e57. PubMed ID: 21364662
[TBL] [Abstract][Full Text] [Related]
17. Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression.
Suzuki J; Chen YY; Scott GK; Devries S; Chin K; Benz CC; Waldman FM; Hwang ES
Clin Cancer Res; 2009 May; 15(9):3163-71. PubMed ID: 19383825
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin.
De Cesare M; Cominetti D; Doldi V; Lopergolo A; Deraco M; Gandellini P; Friedlander S; Landesman Y; Kauffman MG; Shacham S; Pennati M; Zaffaroni N
Oncotarget; 2015 May; 6(15):13119-32. PubMed ID: 25948791
[TBL] [Abstract][Full Text] [Related]
19. HDAC6 is a microtubule-associated deacetylase.
Hubbert C; Guardiola A; Shao R; Kawaguchi Y; Ito A; Nixon A; Yoshida M; Wang XF; Yao TP
Nature; 2002 May; 417(6887):455-8. PubMed ID: 12024216
[TBL] [Abstract][Full Text] [Related]
20. CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status.
Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Hyun YL; Choi J
Breast Cancer Res Treat; 2011 Nov; 130(2):365-75. PubMed ID: 21184271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
